Literature DB >> 1538504

A prospective, randomized trial of Unna's boot versus Duoderm CGF hydroactive dressing plus compression in the management of venous leg ulcers.

P R Cordts1, L M Hanrahan, A A Rodriguez, J Woodson, W W LaMorte, J O Menzoian.   

Abstract

Leg ulcers caused by chronic venous insufficiency plague an estimated 500,000 Americans, but there have been few improvements in conservative treatment in this century, and Unna's boot continues to be a mainstay of therapy. A recent report suggests that Duoderm CGF dressing provides greater patient comfort and enhanced compliance, but Duoderm alone (without compression) resulted in slower healing compared with Unna's boot. We enrolled 30 patients (30 ulcers) in a clinical trial to compare Duoderm CGF plus compression (Coban wrap) to Unna's boot. No significant difference was observed between the two groups with respect to age, sex, initial ulcer area, ulcer duration, or extent of venous insufficiency by duplex scan. Eight of 16 ulcers (50%) in the Duoderm group healed completely versus 6 of 14 ulcers (43%) in the Unna's boot group (p = 0.18). Healing rates (square centimeters per week) correlated significantly with initial ulcer area and initial ulcer perimeter for both groups but best correlated with initial ulcer perimeter (r = 0.88 with Duoderm, p less than 0.0001; r = 0.80 with Unna's boot, p less than 0.002). After adjusting for differences in initial ulcer perimeter, healing rates were significantly faster for patients on Duoderm than patients on Unna's boot during the first 4 weeks of therapy (0.384 +/- 0.059 cm2/wk/cm perimeter for Duoderm versus 0.135 +/- 0.043 cm2/wk/cm perimeter for Unna's boot; p = 0.002). At 12 weeks patients on Duoderm again appeared to heal faster than those on Unna's boot, although the result did not reach statistical significance (0.049 +/- 0.007 cm2/wk/cm perimeter for Duoderm versus 0.020 +/- 0.017 for Unna's boot, p = 0.11).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538504

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  14 in total

Review 1.  Compression therapy for venous leg ulcers.

Authors:  N Cullum; A Fletcher; A Semlyen; T A Sheldon
Journal:  Qual Health Care       Date:  1997-12

2.  Dressing for a cocaine-induced skin ulcer.

Authors:  R A Blattel
Journal:  Can Fam Physician       Date:  1997-04       Impact factor: 3.275

3.  Chronic Venous Insufficiency.

Authors:  Robert M. Schainfeld
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-04

4.  Evaluation of the use of prognostic information for the care of individuals with venous leg ulcers or diabetic neuropathic foot ulcers.

Authors:  Shanu K Kurd; Ole J Hoffstad; Warren B Bilker; David J Margolis
Journal:  Wound Repair Regen       Date:  2009 May-Jun       Impact factor: 3.617

5.  [Ulcus cruris venosum: surgical debridement, antibiotic therapy and stimulation with thrombocytic growth factors].

Authors:  S Coerper; G Köveker; I Flesch; H D Becker
Journal:  Langenbecks Arch Chir       Date:  1995

Review 6.  Optimal treatment of venous (stasis) ulcers in elderly patients.

Authors:  C Hansson
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

Review 7.  Optimizing Wound Bed Preparation With Collagenase Enzymatic Debridement.

Authors:  Stanley K McCallon; Dorothy Weir; John C Lantis
Journal:  J Am Coll Clin Wound Spec       Date:  2015-08-15

Review 8.  Nanoceutical Adjuvants as Wound Healing Material: Precepts and Prospects.

Authors:  Kaushita Banerjee; Radha Madhyastha; Yuichi Nakajima; Masugi Maruyama; Harishkumar Madhyastha
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 9.  Compression for venous leg ulcers.

Authors:  Susan O'Meara; Nicky Cullum; E Andrea Nelson; Jo C Dumville
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

10.  Evaluating the effectiveness of the customized Unna boot when treating patients with venous ulcers.

Authors:  Bruna Suelen Raymundo Luz; Cristina Souza Araujo; Dênia Amélia Novato Castelli Von Atzingen; Adriana Rodrigues dos Anjos Mendonça; Marcos Mesquita Filho; Mauricéia Lins de Medeiros
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.